Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Some preventive treatments, such as statins and antihypertensive drug classes, differ in their relative effectiveness in preventing stroke versus coronary events. However, guidelines for secondary prevention of stroke are based partly on observations that fatal coronary events on long-term follow-up after TIA and stroke exceed fatal recurrent strokes. However, given the substantial fall in population incidence of coronary events in recent decades, it is uncertain whether this excess coronary risk remains.

Original publication

DOI

10.1136/jnnp-2013-306573.5

Type

Journal article

Journal

J Neurol Neurosurg Psychiatry

Publication Date

11/2013

Volume

84

Addresses

Stroke Prevention Research Unit, University of Oxford.

Keywords

PARKINSON'S DISEASE, STROKE